Authorities expressed concerns over a solvent in the food and pharmaceutical industries mixed with an industrial-grade chemical, posing health risks.
The Drug Regulatory Authority of Pakistan (DRAP) swiftly acted, recalling contaminated cough syrup and raw materials. Imported propylene glycol (PEG) may be adulterated, causing organ failure.
Local industries receive suspicious mixtures, raising fears of harmful contaminants. Pharmaceutical experts highlight the unusual pricing of locally obtained PEG, suggesting industrial-grade mixing.
DRAP’s stringent measures include halting chemical imports without thorough testing, aiming to prevent health hazards. The focus is on identifying importers and testing solvents at entry points to safeguard public health.
The urgency stems from global incidents of severe health issues due to contaminants in therapeutic goods. The DRAP emphasizes collaboration with Customs authorities to ensure extensive sampling and prevent potential health crises in Pakistan.